1 APPG membership (as of 30 May 2024)
Nutrition: Science and Health8 Former APPG memberships
Dementia, First Do No Harm, Haemophilia and Contaminated Blood, Ireland and the Irish in Britain, Malaria and Neglected Tropical Diseases, Sepsis, Trade and Export Promotion, Trade and InvestmentDivision Voting information
Debates during the 2024 Parliament
Speeches made during Parliamentary debates are recorded in Hansard. For ease of browsing we have grouped debates into individual, departmental and legislative categories.
Sparring Partners
Leader of the House of Lords and Lord Privy Seal
(2 debate interactions)
Parliamentary Under-Secretary (Department of Health and Social Care)
(1 debate interactions)
Department Debates
(1 debate contributions)
(1 debate contributions)
(1 debate contributions)
Legislation Debates
Baroness Ritchie of Downpatrick has not made any spoken contributions to legislative debateLords initiatives
These initiatives were driven by Baroness Ritchie of Downpatrick, and are more likely to reflect personal policy preferences.
Baroness Ritchie of Downpatrick has not introduced any legislation before Parliament
Baroness Ritchie of Downpatrick has not co-sponsored any Bills in the current parliamentary sitting
Latest 2 Written Questions
(View all written questions)2 Department of Health and Social Care Questions
(View all Baroness Ritchie of Downpatrick's DHSC questions)An immunisation programme to protect infants with a vaccine during pregnancy will begin in England from 1 September 2024, to protect infants from 2024/25 onwards. The respiratory syncytial virus (RSV) maternal vaccination programme will be delivered by National Health Service trust providers via maternity services and immunisation providers. They will ensure that pregnant women are informed of their eligibility for the RSV vaccine, and are invited for their vaccination. General practices will also be able to deliver the maternal vaccine on an opportunistic basis, or if requested by the patient.
Pregnant women will be offered the immunisation from 28 weeks of pregnancy until full term, to protect their baby during the first six months of life when they are most vulnerable to RSV complications. The programme will be offered year-round. Further to the national programme, the high-risk programme for eligible infants will continue. This will be offered to eligible infants independent of their mother receiving the maternal vaccine.
Parliamentary Under-Secretary (Department of Health and Social Care)
An immunisation programme to protect infants with a vaccine during pregnancy will begin in England from 1 September 2024, to protect infants from 2024/25 onwards. The respiratory syncytial virus (RSV) maternal vaccination programme will be delivered by National Health Service trust providers via maternity services and immunisation providers. They will ensure that pregnant women are informed of their eligibility for the RSV vaccine, and are invited for their vaccination. General practices will also be able to deliver the maternal vaccine on an opportunistic basis, or if requested by the patient.
Pregnant women will be offered the immunisation from 28 weeks of pregnancy until full term, to protect their baby during the first six months of life when they are most vulnerable to RSV complications. The programme will be offered year-round. Further to the national programme, the high-risk programme for eligible infants will continue. This will be offered to eligible infants independent of their mother receiving the maternal vaccine.
Parliamentary Under-Secretary (Department of Health and Social Care)